Literature DB >> 23949705

NGAL and AKI: the end of a myth?

Matthieu Legrand1, Michael Darmon, Michael Joannidis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23949705     DOI： 10.1007/s00134-013-3061-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  20 in total

Review 1.  Dual action of neutrophil gelatinase-associated lipocalin.

Authors:  Kai M Schmidt-Ott; Kiyoshi Mori; Jau Yi Li; Avtandil Kalandadze; David J Cohen; Prasad Devarajan; Jonathan Barasch
Journal:  J Am Soc Nephrol       Date:  2007-01-17       Impact factor: 10.121

2.  Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.

Authors:  Jaya Mishra; Catherine Dent; Ridwan Tarabishi; Mark M Mitsnefes; Qing Ma; Caitlin Kelly; Stacey M Ruff; Kamyar Zahedi; Mingyuan Shao; Judy Bean; Kiyoshi Mori; Jonathan Barasch; Prasad Devarajan
Journal:  Lancet       Date:  2005 Apr 2-8       Impact factor: 79.321

3.  Accuracy of urine NGAL commercial assays in critically ill patients.

Authors:  Matthieu Legrand; Corinne Collet; Etienne Gayat; Juliana Henao; Veronique Giraudeaux; Joaquim Mateo; Jean-Marie Launay; Didier Payen
Journal:  Intensive Care Med       Date:  2012-12-15       Impact factor: 17.440

4.  Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients.

Authors:  Hilde R H de Geus; Jan Bakker; Emmanuel M E H Lesaffre; Jos L M L le Noble
Journal:  Am J Respir Crit Care Med       Date:  2010-10-08       Impact factor: 21.405

5.  Neutrophil gelatinase-associated lipocalin: a biomarker in COPD.

Authors:  Tomas M Eagan; Jan K Damås; Thor Ueland; Marianne Voll-Aanerud; Tom E Mollnes; Jon A Hardie; Per S Bakke; Pål Aukrust
Journal:  Chest       Date:  2010-05-21       Impact factor: 9.410

6.  Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance.

Authors:  David R McIlroy; Gebhard Wagener; H Thomas Lee
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

7.  Assays of urine levels of HNL/NGAL in patients undergoing cardiac surgery and the impact of antibody configuration on their clinical performances.

Authors:  Linjun Cai; Jan Borowiec; Shengyuan Xu; Wenyu Han; Per Venge
Journal:  Clin Chim Acta       Date:  2009-02-07       Impact factor: 3.786

8.  Kidney NGAL is a novel early marker of acute injury following transplantation.

Authors:  Jaya Mishra; Qing Ma; Caitlin Kelly; Mark Mitsnefes; Kiyoshi Mori; Jonathan Barasch; Prasad Devarajan
Journal:  Pediatr Nephrol       Date:  2006-04-14       Impact factor: 3.714

9.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 10.  Clinical review: Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients.

Authors:  Peter B Hjortrup; Nicolai Haase; Mik Wetterslev; Anders Perner
Journal:  Crit Care       Date:  2013-04-24       Impact factor: 9.097
View more
  5 in total

1.  Biomarkers for AKI improve clinical practice: no.

Authors:  Marlies Ostermann; Michael Joannidis
Journal:  Intensive Care Med       Date:  2014-11-12       Impact factor: 17.440

2.  Incidence and risk factors for early renal dysfunction after liver transplantation.

Authors:  Patricia Wiesen; Paul B Massion; Jean Joris; Olivier Detry; Pierre Damas
Journal:  World J Transplant       Date:  2016-03-24

3.  Alpha1-microglobulin as an early biomarker of sepsis-associated acute kidney injury: a prospective cohort study.

Authors:  I Terzi; V Papaioannou; N Papanas; C Dragoumanis; A Petala; V Theodorou; T Gioka; V Vargemezis; E Maltezos; I Pneumatikos
Journal:  Hippokratia       Date:  2014 Jul-Sep       Impact factor: 0.471

Review 4.  Management of acute renal replacement therapy in critically ill cirrhotic patients.

Authors:  Jimena Del Risco-Zevallos; Alicia Molina Andújar; Gastón Piñeiro; Enric Reverter; Néstor David Toapanta; Miquel Sanz; Miquel Blasco; Javier Fernández; Esteban Poch
Journal:  Clin Kidney J       Date:  2022-01-28

5.  Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients.

Authors:  Delphine Daubin; Jean Paul Cristol; Anne Marie Dupuy; Nils Kuster; Noémie Besnard; Laura Platon; Aurèle Buzançais; Vincent Brunot; Fanny Garnier; Olivier Jonquet; Kada Klouche
Journal:  PLoS One       Date:  2017-01-13       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.